生命科学软件公司Certara, Inc.（CERT）今日盘前股价大涨5.14%，引发市场关注。这一涨幅出现在公司发布2025财年第二季度财报之后，尽管财报显示公司业绩未达分析师预期。
根据公司公布的财报，Certara第二季度调整后每股收益为0.07美元，低于分析师预期的0.10美元。然而，公司季度营收达到1.0457亿美元，同比增长12.1%，略低于分析师预期的1.0503亿美元。尽管公司报告当季净亏损197万美元，但调整后EBITDA达到3190万美元，显示出公司运营状况的改善。
虽然季度业绩未达预期，但投资者似乎更关注公司的长期发展前景。分析师对Certara保持乐观态度，目前对该公司股票的平均评级为"买入"，12个月目标价中位数为15.00美元，较上一交易日收盘价9.53美元高出约36.5%。这种积极的分析师展望可能是推动股价上涨的主要因素，投资者可能认为当前价格提供了较好的入场机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.